Jakob K Kristjansson

Title: Innovations of Jakob K Kristjansson

Introduction

Jakob K Kristjansson is a notable inventor based in Reykjavik, Iceland. He has made significant contributions to the field of biotechnology, particularly in the study of bacteriophages. With a total of 2 patents, his work has implications for genetic research and therapeutic applications.

Latest Patents

Kristjansson's latest patents include the "RNA ligase of bacteriophage RM 378" and "Bacteriophage RM 378 of a thermophilic host organism." The first patent describes a novel bacteriophage RM 378, detailing the nucleic acids of its genome, including nucleotide sequences of open reading frames (ORFs) and the polypeptides encoded by these nucleic acids. The second patent also focuses on bacteriophage RM 378, emphasizing its genome's nucleic acids and the polypeptides they encode.

Career Highlights

Jakob K Kristjansson is associated with Prokaria Ltd., where he continues to advance his research in bacteriophage technology. His work is pivotal in understanding the genetic makeup of these viruses and their potential applications in various fields.

Collaborations

Some of his notable coworkers include Sigridur Hjörleifsdottir and Gudmundur Oli Hreggvidsson, who contribute to the collaborative efforts in his research endeavors.

Conclusion

Jakob K Kristjansson's innovative work in bacteriophage research highlights his role as a significant inventor in the biotechnology field. His patents pave the way for future advancements in genetic research and therapeutic applications.